三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01530 三生制药

未开盘 12-17 16:08:10

25.800

+0.140

+0.55%

最高25.980	最低24.960	成交量1,875万
今开25.660	昨收25.660	日振幅3.98%
总市值654.80亿	流通市值654.80亿	总股本25.38亿
成交额4.79亿	换手率0.74%	流通股本25.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":25.8,"timestamp":1765958890005,"preClose":25.66,"halted":0,"volume":18747403,"delay":0,"floatShares":2538000000,"shares":2538000000,"eps":0.9531364383714054,"marketStatus":"未开盘","change":0.14,"latestTime":"12-17 16:08:10","open":25.66,"high":25.98,"low":24.96,"amount":478721932,"amplitude":0.039751,"askPrice":25.8,"askSize":28500,"bidPrice":25.78,"bidSize":13500,"shortable":3,"etf":0,"ttmEps":1.0596320619009085,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":0,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":25.66,"dividendRate":0.010034,"openAndCloseTimeList":[[1765935000000,1765944000000],[1765947600000,1765958400000]],"volumeRatio":0.7650920539779983,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"2592996689","title":"远大医药(00512)：自主研发的重磅全球创新放射性核素偶联药物 GPN01530 在美国获批开展临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2592996689","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592996689?lang=zh_cn&edition=full","pubTime":"2025-12-17 18:06","pubTimestamp":1765966009,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 发布公告，集团自主研发的全球创新放射性核素偶联药物 GPN01530 近日获得美国食品药品监督管理局正式批准开展用于诊断实体瘤的 I/II 期临床研究，这标志着集团在核药抗肿瘤诊疗领域的全球化布局上又迈出坚实一步。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1191","01530","BK1583","BK1161","HK0000165453.HKD","00512"],"gpt_icon":0},{"id":"2592910426","title":"12月17日港股药品及生物科技行业沽空数据盘点，信达生物、石药集团、三生制药沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2592910426","media":"证券之星APP","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592910426?lang=zh_cn&edition=full","pubTime":"2025-12-17 18:06","pubTimestamp":1765965972,"startTime":"0","endTime":"0","summary":"证券之星消息，12月17日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有83只被沽空，总沽空股数为1.01亿股，总沽空金额为15.15亿元（港元），而当日药品及生物科技行业的总成交金额为89.09亿元（港元），沽空比例为17.0%。从沽空金额来看，信达生物、石药集团、三生制药沽空金额位居行业前三，分别为1.65亿港元、1.52亿港元、1.2亿港元。沽空与卖空含义相同，即在并不持有股票的前提下，通过借入股票获得筹码进而卖出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217181708a45681d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217181708a45681d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1521","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU0067412154.USD","LU2097828805.USD","IE0008368742.USD","LU2242644610.SGD","BK1515","BK1589","BK1583","LU1152091168.USD","LU1969619763.USD","LU2097828474.EUR","LU1328277881.USD","01801","LU1951186391.HKD","LU1152091754.HKD","SG9999004220.SGD","IE0008369823.USD","BK1593","LU1008478684.HKD","LU0072913022.USD","01093","LU0140636845.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","LU1226288170.HKD","LU1813983027.USD","01530","LU1960683339.HKD","LU0315179316.USD","LU1807302812.USD","LU2097828714.EUR","LU1993786604.SGD","LU0455707207.USD","IE00B543WZ88.USD","LU2328871848.SGD","LU0326950275.SGD","LU2097828631.EUR","IE00BZ08YS42.EUR","HK0000165453.HKD","LU1226288253.USD","BK1191","BK1161","LU0502904849.HKD","LU1226287529.USD","LU2039709279.SGD","LU0501845795.SGD","LU0314109678.HKD","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2592910400","title":"三生制药12月17日获主力加仓167.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592910400","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592910400?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:15","pubTimestamp":1765959353,"startTime":"0","endTime":"0","summary":"12月17日, 三生制药股价涨0.55%，报收25.80元，成交金额4.8亿元，换手率0.74%，振幅3.98%，量比0.76。三生制药今日主力资金净流入167.0万元，上一交易日主力净流入301.3万元。该股近5个交易日下跌7.46%，主力资金累计净流出3491.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1.5亿元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162129a6ad15ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162129a6ad15ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","HK0000165453.HKD","BK1161"],"gpt_icon":0},{"id":"2592962581","title":"每日卖空追踪 | 三生制药 12月16日卖空量成交53.15万股，卖空比例为1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592962581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592962581?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873820,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月16日，跌2.21%，卖空量成交53.15万股，较上一交易日减少70.41%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163318a4519dcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163318a4519dcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1593","BK1161","01530","BK1583"],"gpt_icon":0},{"id":"2590570693","title":"智通港股空仓持单统计|12月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2590570693","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590570693?lang=zh_cn&edition=full","pubTime":"2025-12-12 18:30","pubTimestamp":1765535405,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月5日，未平仓空单比位列前三位为万科企业、中兴通讯、中远海控，空仓比分别为20.57%、17.63%、17.59%。智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；以上涉及的空仓比增加值或减少值为绝对值数。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06865","00354","LU0315179316.USD","09863","82318","01072","LU2242644610.SGD","06613","01880","601318","IE00BZ08YR35.GBP","06680","02899","HK0000306685.HKD","09995","LU0235996351.USD","PAImain","01138","02228","01801","LU2097828631.EUR","LU0417516738.SGD","SG9999004220.SGD","01530","00863","HPAD.SI","LU2476274720.SGD","02382","LU1481107354.HKD","SG9999002463.SGD","01919","02498","09626","PNGAY","LU0320764599.SGD","LU0821914370.USD","LU0370786039.SGD","00763","02013","LU0348767384.USD","LU1211504680.USD","00522","000002","00839","01276","02202","03145"],"gpt_icon":1},{"id":"2591686673","title":"每日卖空追踪 | 三生制药 12月12日卖空量成交57.9万股，卖空比例为2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591686673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591686673?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528220,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月12日，涨0.94%，卖空量成交57.9万股，较上一交易日减少55.01%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121216494295398b3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121216494295398b3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1593","HK0000165453.HKD","BK1583","BK1161"],"gpt_icon":0},{"id":"2590958283","title":"每日卖空追踪 | 三生制药 12月10日卖空量成交153.65万股，卖空比例为9.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590958283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590958283?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355422,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月10日，跌0.92%，卖空量成交153.65万股，较上一交易日减少52.72%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163315979a4662&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163315979a4662&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","BK1583","01530","HK0000165453.HKD"],"gpt_icon":0},{"id":"2590875345","title":"三生制药(01530)根据配售协议发行1.05亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590875345","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590875345?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:11","pubTimestamp":1765282286,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，于2025年12月9日，根据2025年12月2日签订的配售协议发行1.05亿股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","01530","BK1583","BK1593","BK1161"],"gpt_icon":0},{"id":"2590739279","title":"港股异动 | 三生制药(01530)现跌近5% 公司近期配股净筹超30亿港元 拟分拆蔓迪国际上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2590739279","media":"智通财经","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590739279?lang=zh_cn&edition=full","pubTime":"2025-12-09 14:00","pubTimestamp":1765260007,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药现跌近5%，截至发稿，跌4.93%，报27.76港元，成交额7.04亿港元。消息面上，三生制药本月初发布公告称，计划以29.62港元/股的价格配售1.05亿股股份，筹资净额约30.87亿港元。值得注意的是，今年11月，三生制药宣布拆分旗下脱发治疗公司蔓迪国际上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379221.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"港股异动 | 三生制药(01530)现跌近5% 公司近期配股净筹超30亿港元 拟分拆蔓迪国际上市","news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1583","HK0000165453.HKD","01530","BK1161"],"gpt_icon":0},{"id":"2590181443","title":"1000亿美元授权交易的背后：中国创新药全球价值突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2590181443","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590181443?lang=zh_cn&edition=full","pubTime":"2025-12-09 11:43","pubTimestamp":1765251807,"startTime":"0","endTime":"0","summary":"恒瑞医药与GSK的120亿美元合作协议落定，当信达生物与武田制药114亿美元的联手刷屏行业，2025年中国创新药对外授权交易迎来爆发。有数据显示，仅2025年前三季度，中国创新药对外授权总金额已突破1000亿美元。而授权交易数据的爆发式增长，直观展现了全球市场对中国创新价值的认可。业内表示，中国创新药的价值跃升，本质是研发实力与成本优势的双重赋能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209114610a72c6f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209114610a72c6f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","LU2097828474.EUR","BK1583","LU2097828805.USD","HK0000165453.HKD","BK1161","LU2242644610.SGD","01276","06978","BK1589","LU1969619763.USD","LU2097828557.USD","09995","LU0502904849.HKD","03692","LU2097828631.EUR","LU2097828714.EUR","LU2328871848.SGD","LU0455707207.USD","LU2488822045.USD","BK1574","01801"],"gpt_icon":0},{"id":"2590393913","title":"招银国际：2025医保目录公布延续支持创新 料CXO业下半年修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2590393913","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590393913?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:03","pubTimestamp":1765245827,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，2025年版基本医保目录以及首版商保目录发布，延续支持创新，料CXO行业有望在下半年迎来业绩修复。推荐买入三生制药(01530)、固生堂(02273)、药明合联(02268)、巨子生物(02367)、信达生物(01801)、中国生物制药(01177)。报告表示，多家企业的核心创新品种获纳入医保。该行认为，宏观环境及老龄化的挑战下，医保收支压力仍在，关注国家集采续约。尽管首版商保目录短期对于产品销售的拉动有限，由于商业保险的规模不大，认为商保目录的意义重大，或将开启中国商业医疗保险扩容的道路，成为中国多元化支付体系发展开端。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","LU2488822045.USD","BK1141","LU2242644610.SGD","01177","LU2097828557.USD","02273","BK1161","LU1969619763.USD","BK1583","LU0502904849.HKD","BK1589","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","HK0000165453.HKD","BK1515","02367","02268","BK1219","LU2097828474.EUR","LU0455707207.USD","SG9999004311.SGD","01530","LU2097828631.EUR","CXO","LU2328871848.SGD","LU2097828805.USD","01801","LU2097828714.EUR","IE00BZ08YR35.GBP","SG9999014674.SGD","BK1593","BK1207","BK1521"],"gpt_icon":0},{"id":"2589565643","title":"每日卖空追踪 | 三生制药 12月08日卖空量成交83.7万股，卖空比例为4.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589565643","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589565643?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182621,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月08日，跌1.28%，卖空量成交83.7万股，较上一交易日减少47.34%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163310a72aae9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163310a72aae9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","HK0000165453.HKD","01530","BK1593","BK1161"],"gpt_icon":0},{"id":"2589035656","title":"2025年国内创新药BD 交易火热，合作模式呈多样化","url":"https://stock-news.laohu8.com/highlight/detail?id=2589035656","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589035656?lang=zh_cn&edition=full","pubTime":"2025-12-08 15:06","pubTimestamp":1765177604,"startTime":"0","endTime":"0","summary":"据报告显示，2025前三季度中国创新药对外授权总金额已突破1000亿美元。值得注意的是，随着创新药BD合作的不断增多，更具创新性的合作模式也在不断涌现。12月5日，信达生物宣布与武田制药所达成的全球战略合作已满足所有交割条件，协议已正式生效。该合作于 2025 年 10 月 22 日宣布，信达生物就两个在研管线的权益加一个管线的独家选择权与武田制药达成合作，获得12亿美元首付款，潜在交易总金额高达114亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208150814a72a7fcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208150814a72a7fcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01276","06978","BK1593","BK1583","HK0000165453.HKD","01530","BK1161"],"gpt_icon":0},{"id":"2589551173","title":"医药生物行业：ESMO ASIA与ASH共绘双抗/ADC/CAR-T技术新蓝图 前沿疗法迎来验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2589551173","media":"中泰证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589551173?lang=zh_cn&edition=full","pubTime":"2025-12-08 00:00","pubTimestamp":1765123200,"startTime":"0","endTime":"0","summary":"本周沪深300 指数上涨1.28%，医药生物下跌0.74%，处于31个一级子行业第21 位。12 月第一周，ESMO Asia 和ASH 会议的数据预热对市场情绪产生了积极影响。在ASH 会议上，体内生成CAR-T 技术展示了其颠覆传统复杂制备流程的潜力；在ESMO Asia 上，针对B7-H3 等靶点的ADC药物也在NSCLC 等实体瘤中显示出积极疗效。针对EGFR 突变，双特异性抗体联合TKI 正在重新定义一线标准。在2025 年的ASH 会议上，体内CAR-T 疗法无疑是备受瞩目的焦点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208150630a72a7eff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208150630a72a7eff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","09939","BK1161","02096","01530","BK1583","BK1515"],"gpt_icon":0},{"id":"2589358833","title":"医药行业2025Q3持仓分析：医药持仓环比略降低 医药主动基金加仓其他生物制品、减仓化学制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2589358833","media":"西南证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589358833?lang=zh_cn&edition=full","pubTime":"2025-12-08 00:00","pubTimestamp":1765123200,"startTime":"0","endTime":"0","summary":"2025Q3医药总持仓变化情况：25Q3全部公募基金占比9.67%，环比-0.21pp；剔除主动医药基金占比6.74%，环比-0.74pp；再剔除指数基金医药持仓占比5.13%，环比+0.73pp；申万医药板块市值占比为7.83%，环比+1.52pp。2025Q3医药基金医药子行业重仓市值占比变化情况：环比增加前三：其他生物制品占比14.3%，环比增加最大，+3.43pp；医疗研发外包占比9.2%，环比+1.65pp，疫苗占比0.01%，环比+0.01pp。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208150631a43aca57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208150631a43aca57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1961090484.USD","LU0634319403.HKD","LU2488822045.USD","IE00BPRC5H50.USD","09995","09939","LU2778985437.USD","LU2476274720.SGD","01530","IE00B5MMRT66.SGD","LU0348735423.USD","LU0540923850.HKD","BK1161","LU0348766576.USD","BK1515","LU0417516902.SGD","LU2476274308.USD","LU1720050803.USD","LU0348767384.USD","LU0561508036.HKD","LU2399975544.HKD","LU1794554557.SGD","IE00B543WZ88.USD","LU0348825331.USD","LU0417516738.SGD","LU0417516571.SGD","09926","LU0348783233.USD","LU0348784397.USD","BK1574","LU0348827113.USD"],"gpt_icon":0},{"id":"2589809166","title":"紫杉醇口服溶液成功纳入2025年国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589809166","media":"三生制药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589809166?lang=zh_cn&edition=full","pubTime":"2025-12-07 19:29","pubTimestamp":1765106970,"startTime":"0","endTime":"0","summary":"News今天，国家医疗保障局正式公布了《国家基本医疗保险、工伤保险和生育保险药品目录》。三生制药与上海海和药物研究开发股份有限公司合作产品紫杉醇口服溶液成功纳入2025年国家医保目录。新版目录将于2026年1月1日起正式执行。紫杉醇口服溶液已于2025年4月被正式纳入《CSCO胃癌诊疗指南》，作为晚期胃癌患者二线治疗的I级推荐（1A类）方案2。目前，紫杉醇口服溶液乳腺癌适应症上市申请已获受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251207202309a4394e62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251207202309a4394e62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","HK0000165453.HKD","01530","BK1161"],"gpt_icon":0},{"id":"2589402852","title":"【券商聚焦】交银国际：医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，2025年10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓从年中起亦呈回落态势，但内外资加大创新药布局的大方向不变。而外资则更积极，聚焦创新主线中的龙头及产业链上游，包括恒瑞医药、君实生物和荣昌生物等创新药，及康龙化成、药明康德和泰格医药等CXO标的。12月，行业仍有充足催化剂，包括各项学术大会、医保谈判结果公布、美联储潜在降息等，板块投资情绪有望稳中有升。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU1794554557.SGD","LU0348766576.USD","01789","03933","LU0417516738.SGD","LU2488822045.USD","HK0000165453.HKD","LU0634319403.HKD","BK1588","01530","SG9999004311.SGD","LU2778985437.USD","02196","LU2399975544.HKD","BK1147","02228","02367","LU0640798160.USD","LU1303224171.USD","SG9999014674.SGD","IE00B5MMRT66.SGD","09926","BK1583","BK1500","IE00BPRC5H50.USD","LU0561508036.HKD","09688","LU1251922891.USD","01099","LU0348827113.USD","BK1161","IE00B543WZ88.USD","LU0540923850.HKD","BK1141","LU1770034418.SGD","LU0417516902.SGD","02268","06160","BK1585","BK1617","LU2476274308.USD","LU2328871848.SGD","LU2476274720.SGD","BK1197","LU0417516571.SGD","LU0588546209.SGD","03329","BK1593","LU0348825331.USD"],"gpt_icon":1},{"id":"2589852755","title":"交银国际：中国医药1-8批国采接续规则或温和 短期催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852755?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:18","pubTimestamp":1764901122,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，本周恒生医疗保健指数涨0.5%，跑输大市。其中，生物药、处方药及器械板块表现较优于其他板块。本周内资偏向防御，倾向获利了结，主要加仓内生增长稳定的传统及低估创新药厂。而外资则较积极，聚焦创新主线中的龙头及产业链上游，包括创新药及CXO标的。1-8批集采接续采购规则转变为询价模式，交银国际认为此规则下整体降价幅度或有限，对港股处方药厂的影响或小于预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","00013","BK1588","03329","BK1191","HK0000165453.HKD","LU2488822045.USD","BK0028","BK0082","BK1147","600056","SG9999014674.SGD","BK0185","BK1161","BK1583","BK0188","BK1593","02268","01530","BK0175","06996","BK0250","BK1587","BK0010","BK1574","BK1141"],"gpt_icon":0},{"id":"2589321578","title":"12月4日港股药品及生物科技行业沽空数据盘点，药明生物、三生制药、石药集团沽空金额位居行业前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2589321578","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589321578?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:06","pubTimestamp":1764842782,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有79只被沽空，总沽空股数为9208.67万股，总沽空金额为16.44亿元（港元），而当日药品及生物科技行业的总成交金额为116.21亿元（港元），沽空比例为14.14%。从沽空金额来看，药明生物、三生制药、石药集团沽空金额位居行业前三，分别为2.23亿港元、2.03亿港元、1.53亿港元。沽空与卖空含义相同，即在并不持有股票的前提下，通过借入股票获得筹码进而卖出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204181745a4cc6dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204181745a4cc6dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0181495838.USD","LU1152091168.USD","LU0516422440.USD","LU0140636845.USD","BK1161","LU0326950275.SGD","LU0979878070.USD","LU1226287875.USD","LU0320764599.SGD","LU0880133367.SGD","LU0823426308.USD","SG9999002463.SGD","LU1794554557.SGD","LU0359201612.USD","LU0417516902.SGD","LU1807302812.USD","LU1813983027.USD","LU3063872942.SGD","BK1589","LU0043850808.USD","LU0307460666.USD","LU0856984785.SGD","LU0516422952.EUR","LU0327786744.USD","HK0000165453.HKD","LU1688375341.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU1951186391.HKD","LU2039709279.SGD","LU1242518931.SGD","BK1583","LU1242518857.USD","01530","LU1720050803.USD","LU0456846285.SGD","BK1593","LU0456827905.SGD","IE0008368742.USD","SG9999004220.SGD","BK1610","LU1226287792.SGD","LU0823426480.USD","01093","IE00B5MMRT66.SGD","LU0588546209.SGD","02269","LU1328277881.USD","LU0819121731.USD","LU1880383366.USD"],"gpt_icon":0},{"id":"2589983216","title":"每日卖空追踪 | 三生制药 12月04日卖空量成交307.45万股，卖空比例为15.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589983216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589983216?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837023,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月04日，涨1.43%，卖空量成交307.45万股，较上一交易日减少61.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163254a4cc36d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163254a4cc36d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","HK0000165453.HKD","BK1161","01530","BK1593"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":-0.0746},{"period":"1month","weight":-0.2205},{"period":"3month","weight":-0.1747},{"period":"6month","weight":0.2504},{"period":"1year","weight":3.2638},{"period":"ytd","weight":3.2772}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":-0.0347},{"period":"3month","weight":-0.0405},{"period":"6month","weight":0.0824},{"period":"1year","weight":0.2928},{"period":"ytd","weight":0.2696}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营（CDMO）业务。该公司的产品主要应用于血小板减少症（CIT）、慢性肾病（CKD）引起的贫血症、治疗化疗引起的贫血症（CIA）、强直性嵴柱炎（AS）及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003687},{"month":2,"riseRate":0.5,"avgChangeRate":0.007795},{"month":3,"riseRate":0.8,"avgChangeRate":0.121345},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014398},{"month":5,"riseRate":0.7,"avgChangeRate":0.109101},{"month":6,"riseRate":0.8,"avgChangeRate":0.036581},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.038254},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.014022},{"month":9,"riseRate":0.636364,"avgChangeRate":0.027455},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.018307},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059913},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.040612}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}